Cargando…
An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor Responses
Immune checkpoint blockade (ICB) therapy involves the inhibition of immune checkpoint regulators which reverses their limitation of T cell anti-tumor responses and results in long-lasting tumor regression. However, poor clinical response or tumor relapse was observed in some patients receiving such...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856660/ https://www.ncbi.nlm.nih.gov/pubmed/36672244 http://dx.doi.org/10.3390/cells12020309 |